[go: up one dir, main page]

NO923584L - Sammensetning inneholdende ultrafine magnetiske metalloksydpartikler - Google Patents

Sammensetning inneholdende ultrafine magnetiske metalloksydpartikler

Info

Publication number
NO923584L
NO923584L NO92923584A NO923584A NO923584L NO 923584 L NO923584 L NO 923584L NO 92923584 A NO92923584 A NO 92923584A NO 923584 A NO923584 A NO 923584A NO 923584 L NO923584 L NO 923584L
Authority
NO
Norway
Prior art keywords
composition containing
magnetic metal
particles
ultraphine
oxyl
Prior art date
Application number
NO92923584A
Other languages
English (en)
Other versions
NO305636B1 (no
NO923584D0 (no
Inventor
Kyoji Kito
Hideo Nagae
Masakatsu Hasegawa
Yoshio Ito
Akihiro Mizutani
Kimio Hirose
Masahiro Ohgai
Yasuji Yamashita
Nahoko Tozawa
Keiko Yamada
Shusaburo Hokukoku
Original Assignee
Meito Sangyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12001420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO923584(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Meito Sangyo Kk filed Critical Meito Sangyo Kk
Publication of NO923584D0 publication Critical patent/NO923584D0/no
Publication of NO923584L publication Critical patent/NO923584L/no
Publication of NO305636B1 publication Critical patent/NO305636B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • G01N2400/14—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar alpha-D-Glucans, i.e. having alpha 1,n (n=3,4,6) linkages between saccharide units, e.g. pullulan
    • G01N2400/22—Dextran
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/20—Magnetic particle immunoreagent carriers the magnetic material being present in the particle core
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/30—Magnetic particle immunoreagent carriers the magnetic material being dispersed in the polymer composition before their conversion into particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/806—Electrical property or magnetic property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Soft Magnetic Materials (AREA)
  • Compounds Of Iron (AREA)
  • Hard Magnetic Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
NO923584A 1991-01-19 1992-09-15 Sammensetning inneholdende ultrafine magnetiske metalloksydpartikler, samt MRI-kontrastmiddel derav NO305636B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1951291 1991-01-19
PCT/JP1992/000031 WO1992012735A1 (en) 1991-01-19 1992-01-17 Composition containing ultrafine particles of magnetic metal oxide

Publications (3)

Publication Number Publication Date
NO923584D0 NO923584D0 (no) 1992-09-15
NO923584L true NO923584L (no) 1992-11-12
NO305636B1 NO305636B1 (no) 1999-07-05

Family

ID=12001420

Family Applications (2)

Application Number Title Priority Date Filing Date
NO923584A NO305636B1 (no) 1991-01-19 1992-09-15 Sammensetning inneholdende ultrafine magnetiske metalloksydpartikler, samt MRI-kontrastmiddel derav
NO2002003C NO2002003I2 (no) 1991-01-19 2002-05-16 Ferukarbotran og L (+)- melkesyre

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2002003C NO2002003I2 (no) 1991-01-19 2002-05-16 Ferukarbotran og L (+)- melkesyre

Country Status (13)

Country Link
US (1) US5328681A (no)
EP (1) EP0525199B2 (no)
JP (1) JP2921984B2 (no)
AT (1) ATE179894T1 (no)
AU (1) AU652804B2 (no)
CA (1) CA2078679C (no)
DE (2) DE10199065I2 (no)
DK (1) DK0525199T4 (no)
ES (1) ES2131067T5 (no)
LU (1) LU91003I2 (no)
NL (1) NL300088I1 (no)
NO (2) NO305636B1 (no)
WO (1) WO1992012735A1 (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0689430B1 (de) * 1993-03-17 1997-08-13 Silica Gel Ges.M.B.H Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben
CA2182213A1 (en) * 1994-01-28 1995-08-03 William George Gorman Oral magnetic particle formulation
DE4428851C2 (de) * 1994-08-04 2000-05-04 Diagnostikforschung Inst Eisen enthaltende Nanopartikel, ihre Herstellung und Anwendung in der Diagnostik und Therapie
DE19509694A1 (de) * 1995-03-08 1996-09-19 Schering Ag Verwendung von Magnetiten zur Bestimmung der Perfusion von menschlichem Gewebe mittels MR-Diagnostik
GB9600427D0 (en) * 1996-01-10 1996-03-13 Nycomed Imaging As Contrast media
EA001336B1 (ru) 1996-01-10 2001-02-26 Никомед Имеджинг Ас Контрастное вещество
US5855868A (en) * 1996-04-01 1999-01-05 Nycomed Imaging As Method of T1 -weighted resonance imaging of RES organs
FR2749082B1 (fr) * 1996-05-24 1998-06-26 Bio Merieux Particules superparamagnetiques et monodispersees
IL128057A (en) * 1996-08-05 2001-08-26 Schering Ag Process for the production of contrast media
US6713173B2 (en) 1996-11-16 2004-03-30 Nanomagnetics Limited Magnetizable device
US6815063B1 (en) 1996-11-16 2004-11-09 Nanomagnetics, Ltd. Magnetic fluid
US20060003163A1 (en) * 1996-11-16 2006-01-05 Nanomagnetics Limited Magnetic fluid
GB2319253A (en) 1996-11-16 1998-05-20 Eric Leigh Mayes Composition, for use in a device, comprising a magnetic layer of domain-separated magnetic particles
US6986942B1 (en) 1996-11-16 2006-01-17 Nanomagnetics Limited Microwave absorbing structure
US6725078B2 (en) * 2000-01-31 2004-04-20 St. Louis University System combining proton beam irradiation and magnetic resonance imaging
EP1264181B1 (en) 2000-03-06 2007-06-06 Dade Behring Marburg GmbH Carriers coated with polysaccharides, their preparation and use
US6743395B2 (en) * 2000-03-22 2004-06-01 Ebara Corporation Composite metallic ultrafine particles and process for producing the same
US7169618B2 (en) * 2000-06-28 2007-01-30 Skold Technology Magnetic particles and methods of producing coated magnetic particles
DE10154016B4 (de) * 2001-10-26 2004-02-12 Berlin Heart Ag Magnetflüssigkeit und Verfahren zur ihrer Herstellung
US20030185757A1 (en) * 2002-03-27 2003-10-02 Mayk Kresse Iron-containing nanoparticles with double coating and their use in diagnosis and therapy
AU2003266501A1 (en) * 2002-08-16 2004-03-03 Admetec Co., Ltd. Heating method and heating apparatus therefor
TW200423949A (en) * 2003-01-31 2004-11-16 Otsuka Pharma Co Ltd Auxiliary agent used for the cancer medical treatment by dielectric heating, and cancer medical treatment method
FR2861994A1 (fr) * 2003-11-12 2005-05-13 Guerbet Sa Nouvel agent de diagnostic pour l'irm dans les pathologies impliquant des proteinases
EP2353504B1 (en) 2004-02-20 2013-01-16 University of Florida Research Foundation, Inc. System for delivering conformal radiation therapy while simultaneously imaging soft tissue
JP3822229B2 (ja) * 2004-05-27 2006-09-13 松下電器産業株式会社 基板上への微粒子配列体の形成方法
JP5082446B2 (ja) * 2004-11-10 2012-11-28 コニカミノルタエムジー株式会社 被覆磁性粒子含有製剤およびその製造方法、並びに診断治療システム
JP5354566B2 (ja) * 2008-07-25 2013-11-27 名糖産業株式会社 カチオン性多糖磁性粒子複合体
MX2011003263A (es) * 2008-09-29 2011-04-21 Vifor Int Ag Receptaculo y metodo para almacenar y suministrar un liquido y una preparacion medicinal liquida.
IT1398263B1 (it) 2010-03-04 2013-02-22 Monzani Nanoparticelle magnetiche di ossido di ferro a dimensione controllata per la diagnosi ed il trattamento di neoplasie avanzate e metastatiche
DE102011112898A1 (de) 2011-09-08 2013-03-14 Charité - Universitätsmedizin Berlin Nanopartikuläres Phosphatadsorbens basierend auf Maghämit oder Maghämit/Magnetit, dessen Herstellung und Verwendungen
US10561861B2 (en) 2012-05-02 2020-02-18 Viewray Technologies, Inc. Videographic display of real-time medical treatment
CN108452443B (zh) 2012-10-26 2021-05-18 优瑞技术公司 利用对放射疗法的生理反应的成像对治疗评估的系统
JP6535857B2 (ja) * 2015-03-16 2019-07-03 国立大学法人 岡山大学 γ−酸化鉄の製造方法
KR20180120705A (ko) 2016-03-02 2018-11-06 뷰레이 테크놀로지스 인크. 자기 공명 영상을 이용한 입자 치료
EP3554635B1 (en) 2016-12-13 2021-01-20 ViewRay Technologies, Inc. Radiation therapy systems
CN116036499A (zh) 2017-12-06 2023-05-02 优瑞技术公司 多模态放射疗法的优化
US11209509B2 (en) 2018-05-16 2021-12-28 Viewray Technologies, Inc. Resistive electromagnet systems and methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001288A (en) * 1965-09-15 1977-01-04 Howard S. Gable Magnetic organo-iron compounds
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
SE463651B (sv) * 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel
AU4634685A (en) * 1984-06-22 1986-01-24 R.L. Veech Electrolyte solutions and in vivo use thereof
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
JPH0616444B2 (ja) * 1986-03-05 1994-03-02 鹿島石油株式会社 磁性ミクロスフエアの製造方法
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US5102652A (en) * 1986-07-03 1992-04-07 Advanced Magnetics Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US5160726A (en) * 1990-02-15 1992-11-03 Advanced Magnetics Inc. Filter sterilization for production of colloidal, superparamagnetic MR contrast agents
SE8704157L (sv) * 1987-10-26 1989-04-27 Carbomatrix Ab C O Ulf Schroed Superparamagnetiska partiklar och foerfarande foer framstaellning daerav samt anvaendning
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
JP2726520B2 (ja) * 1989-10-20 1998-03-11 名糖産業株式会社 有機磁性複合体

Also Published As

Publication number Publication date
NO305636B1 (no) 1999-07-05
US5328681A (en) 1994-07-12
CA2078679C (en) 2006-12-05
WO1992012735A1 (en) 1992-08-06
DE69229150T2 (de) 1999-09-30
CA2078679A1 (en) 1992-07-20
DE10199065I2 (de) 2004-09-23
DE69229150T3 (de) 2005-01-05
NO923584D0 (no) 1992-09-15
EP0525199A4 (en) 1994-08-17
EP0525199B1 (en) 1999-05-12
NO2002003I2 (no) 2005-04-04
JP2921984B2 (ja) 1999-07-19
AU1168992A (en) 1992-08-27
DE69229150D1 (de) 1999-06-17
ES2131067T3 (es) 1999-07-16
EP0525199A1 (en) 1993-02-03
DK0525199T3 (da) 1999-11-01
ES2131067T5 (es) 2004-10-16
LU91003I2 (en) 2003-03-24
DE10199065I1 (de) 2002-02-21
EP0525199B2 (en) 2004-04-14
DK0525199T4 (da) 2004-06-01
AU652804B2 (en) 1994-09-08
ATE179894T1 (de) 1999-05-15
NL300088I1 (nl) 2002-07-01

Similar Documents

Publication Publication Date Title
NO923584L (no) Sammensetning inneholdende ultrafine magnetiske metalloksydpartikler
NO304351B1 (no) Oksydert kompleks av et vannoppl°selig karboksydpolysakkarid og magnetisk jernoksyd, samt kontrastmedier derav
DE68927189D1 (de) Arzneimittel, die Lanthionin enthaltenden Bacteriozin enthalten, zur Verwendung als Bakterizide
DE3650644D1 (de) Magnetische Polymerpartikeln
NO171949C (no) Fremgangsmaate for fremstilling av et farmasoeytisk mikroinnkapslet preparat
IT8323311A0 (it) Particolarmente per l'infusione di dispositivo e procedimento per medicine od altri liquidi medicali l'infusione di medicazioni, in un organismo vivente.
ATE81588T1 (de) Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
NO934424L (no) Anvendelse av tyloxapol som nanopartikkelformig stabilisator og dispergeringsmiddel
ATE56991T1 (de) Mittel zur bestimmung von peroxidase-aktivitaet mit stabilisator, verfahren zur herstellung und seine verwendung.
Moorhatch et al. Interactions between drugs and plastic intravenous fluid bags, part ii: leaching of chemicals from bags containing various solvent media
ATE88738T1 (de) Waesserige zusammensetzungen, welche eine kationische verbindung und xanthangummi enthalten.
FR2609394B1 (fr) Solution aqueuse contenant un acide quinolone carboxylique
DE69000713D1 (de) Wismuthaltiges arzneipraeparat.
DE69001734D1 (de) Aeusserlich anzuwendende amusulosin enthaltende arzneizubereitung.
EP0334956A4 (en) HEMOLYSIS INHIBITOR AND MEDICAL RESIN COMPOUND, MEDICAL INSTRUMENT AND BLOOD PRESERVATIVE LIQUID THAT CONTAINS IT.
EP0373388A3 (de) Penemderivate und Verfahren zu ihrer Herstellung
Mandel A New Anticoagulant, Vitamin B6: Results of a Comparative Study with Hydroxychloroquine Sulphate, in vitro
Chae et al. The Effects of Chlorpromazine on Serum Prolactin in Schizophrenic Patients and Its Relationship to Clinical Responses
Bode Limulus polyphemus-- a model for a sepsis caused by gram negative bacteria on sea-animals and humans.).
Balakliets et al. Phagocytosis of chloramine B sensitive and resistant staphylococci isolated from healthy persons and patients
FR2627487B1 (fr) Nouveau derive de l'acide valproique, procede de preparation de ce compose ainsi que medicament antiepileptique le contenant
UA9626A (uk) Спосіб діагностики вперше виявленого туберкульозу легень
KR900008215A (ko) 철 이온의 용출 방지 방법 및 장치
ITVR910102A0 (it) Dispositivo per l'analisi del sangue o di altri liquidi organici

Legal Events

Date Code Title Description
SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: FERUKARBOTRAN; NAT. REG. NO/DATE: NO , 01-4597 20011119; FIRST REG. NO/DATE: SE , 17193 20010319

Spc suppl protection certif: 2002003

Filing date: 20020516

Extension date: 20160319

MK1K Patent expired
SPCX Expiry of an spc

Free format text: PRODUCT NAME: FERUKARBOTRAN; NAT. REG. NO/DATE: NO , 01-4597 20011119; FIRST REG. NO/DATE: SE , 17193 20010319

Spc suppl protection certif: 2002003

Effective date: 20160319